The genomic landscape of pediatric ACC is characterized by copy-neutral loss of heterozygosity of chromosomes 11 and 17, which is associated with germline TP53 pathogenic variants, insulin-like growth factor-2 overexpression, and somatic mutations in ATRX and CTNNB1 (16). Here, TP53 is linked to adrenal cortex carcinoma.